Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02594735 · ClinicalTrials.gov registry record · Phase 4
Abatacept in Juvenile Dermatomyositis
A Phase 4 study, sponsored by George Washington University.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT02594735 is a Phase 4 study that has completed, run by George Washington University. The registered enrollment target is 10 participants.
The verdict
NCT02594735, a Phase 4 study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of subcutaneous abatacept in 10 patients seven years of age and older with refractory JDM.
Interventions
- DRUG Abatacept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-11 |
| Est. Completion | 2021-10-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02594735
The ClinicalTrials.gov registry entry for NCT02594735 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Abatacept is the first listed.
NCT02594735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02594735 about?
NCT02594735 is a clinical study titled "Abatacept in Juvenile Dermatomyositis". The purpose of this study is to assess the safety and efficacy of subcutaneous abatacept in 10 patients seven years of age and older with refractory JDM.
What is the current status of trial NCT02594735?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2015-11. Estimated completion is 2021-10-22.
What interventions are being tested in trial NCT02594735?
The interventions under investigation include: Abatacept (DRUG).
Who is sponsoring clinical trial NCT02594735?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.